Senior Statistical Analyst - Programmer (Hybrid) at Abbvie

Abbvie

North Chicago, IL, us·5h ago

Entry LevelFull-time

Salary Range

$51,000 - $69,000 /year

Estimated

This salary is estimated based on similar roles. The actual salary may vary.

The role of the Senior Statistical Analyst is to perform statistical programming activities for all assigned Phase I-IV clinical studies sponsored by AbbVie and its partners. This position performs statistical programming for clinical studies, integrated summaries, and in support of responses to requests from regulatory authorities.  This position can serve as a study lead for an assigned study.          Responsibilities: • Leads the statistical programming activities, and provide programming and documentation support for multiple studies with high quality • Review statistical analysis plans for all assigned studies and integrated summaries in conjunction with program lead and provide comments to study biostatistician • Create ADaM data set specifications and data set for all assigned studies and integrated summaries • Ensure study analysis is consistent with standard templates and specifications • Contribute to submission support and support urgent regulatory agency requests • Follow timelines for assigned study tasks • Coordinate own task assignments • Participating in a Statistical Programming process improvement initiative • Manage timelines and ensure good communication with CROs/FSPs, internal programmers, statistics, data management, medical writing, regulatory publishing and clinical operations. • Oversee programming tasks for a single study • Conduct high level review of deliverables provided by CRO/FSP to ensure good quality and accuracy

Free to sign up. Takes 30 seconds.

Share this job

LinkedIn Twitter Telegram

About Abbvie

Abbvie is a global biopharmaceutical company specializing in the research, development, and commercialization of innovative therapies. Headquartered in North Chicago, Illinois, the company was founded in 2013 following the spin-off of Abbott Laboratories' pharmaceutical division. Abbvie operates at the forefront of the biotechnology and pharmaceutical industries, focusing on addressing complex diseases and improving patient outcomes through scientific advancement. The company's primary products include treatments for immunology, oncology, and neurology, with its flagship drug, Humira, being one of the best-selling medications globally. Abbvie is known for its robust pipeline of investigational therapies, leveraging cutting-edge research and clinical trials to bring novel treatments to market. Its target audience includes patients, healthcare providers, and payers, with a particular emphasis on those suffering from chronic and life-threatening conditions. Key features of Abbvie's offerings include targeted therapies, personalized medicine approaches, and a commitment to regulatory compliance and safety. Abbvie has achieved significant milestones, including maintaining a leading position in the global pharmaceutical market and generating substantial revenue through its innovative portfolio. The company's unique value proposition lies in its dedication to scientific excellence and patient-centric care, supported by a strong pipeline and strategic investments in research and development. Abbvie's market position is further strengthened by its global reach, collaborative partnerships, and a reputation for delivering transformative therapies.